Subscribe

Eric Crombez, MD

Chief medical officer, Ultragenyx Pharmaceuticals

Articles by Eric Crombez, MD

Eric Crombez, MD

Addressing Unmet Needs With Gene Therapy

ByEric Crombez, MD

September 4th 2021

Eric Crombez, PhD, senior vice president and chief medical officer of Ultragenyx Gene Therapy, discussed indications the company is targeting.

Sam Wadsworth, PhD

Selecting AAV Manufacturing Platforms

BySam Wadsworth, PhD,Eric Crombez, MD

August 20th 2021

The chief scientific officer and chief medical officer of Ultragenyx Gene Therapy discussed the company’s future research in gene therapies.

Latest Updated Articles

Selecting AAV Manufacturing Platforms
Published: August 20th 2021 | Updated:

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial

AAVantgarde’s Stargardt Gene Therapy AAVB-039 Garners FDA Orphan Drug Designation, Cleared for Trial in UK

© 2025 MJH Life Sciences^®

All rights reserved.